News und Analysen
Better Buy: Palantir Stock vs. UnitedHealth Group Stock
Two stocks that have been at the center of financial news stories throughout the year are data mining specialist Palantir Technologies (NASDAQ: PLTR) and health insurance giant UnitedHealth Group
Is UnitedHealth a Buy for Long-Term Investors?
With shares down by more than 40%, UnitedHealth Group (NYSE: UNH) is the poorest-performing stock in the Dow Jones Industrial Average so far this year.
Over the last month or so, there has been no
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
How would you like to get paid every quarter (and sometimes every month) to own a stock? That's exactly what happens when you invest in dividend stocks. Sometimes, the amount you are paid to own
Is UnitedHealth Group Stock a Brilliant Bad News Buy?
A healthcare giant. One of only 30 stocks in the Dow Jones Industrial Average. A longtime investors' favorite. UnitedHealth Group (NYSE: UNH) is all those things. However, it's also now a big loser.
Is Buying UnitedHealth Stock Under $300 a No-Brainer?
In this video, I will cover the recent updates regarding UnitedHealth (NYSE: UNH). Watch the short video to learn more, consider subscribing, and click the special offer link below.
*Stock prices
Should You Buy Pfizer Stock Right Now?
If you have an opening in your portfolio for a great stock with solid growth potential and perhaps even a respectable dividend yield, you would do well to give Pfizer (NYSE: PFE) some serious
Is UnitedHealth a Millionaire Maker?
There is a ton of money in America's healthcare system. The country's annual healthcare expenditures push $5 trillion, representing nearly a fifth of the world's largest economy. UnitedHealth (NYSE:
2 Dividend Growth Stocks to Buy and Hold Forever
When broader equities are volatile, it's tempting to focus on what's going to happen in the near term. That's why some investors resort to panic selling -- they anticipate that things will get even
Time to Buy These 3 Cheap Stocks?
The stock market has seen a sharp rebound after the declines in the first quarter, so valuations are not as cheap as they once were. However, I am constantly searching for undervalued stocks.
In
2 Recession-Proof Stocks to Buy and Hold
President Trump's trade policies are sparking concerns about a potential recession. Though it's hard to predict an upcoming economic downturn, it's never a bad idea for investors to buy shares of
Billionaire Ken Griffin Just Bought More Shares of These Unstoppable Dividend Stocks
Some stock-trading platforms enable their users to automatically replicate the positions taken by experienced investors or other famous figures. Many investors might prefer to do their own research
Medtronic Just Announced a Move That Its Shareholders Should Love
Medtronic (NYSE: MDT) is a medical device company with vast and diverse operations. Its business is fairly stable although the stock's returns haven't been all that great. However, it also provides
Huge News for UnitedHealth Stock Investors!
UnitedHealth (NYSE: UNH) is struggling to recover investor trust that was eroded when the company missed its earnings expectations.
*Stock prices used were the afternoon prices of June 2, 2025. The
Down 40% This Year, Is UnitedHealth Group's Dividend in Danger?
UnitedHealth Group (NYSE: UNH) stock has been in a free fall due to a flurry of bad news. Heading into trading this week, shares of the health insurer had crashed more than 40% thus far in 2025
Better High-Yield Dividend Stock to Buy Now: Pfizer vs. Prologis
Investors looking for sources of passive income to fuel their retirement dreams face a dilemma. Should you chase high yields from slow-growing businesses or invest in lower-yield providers with more
Why BioNTech Stock Soared Today
BioNTech (NASDAQ: BNTX), one of the companies made famous for its role developing vaccines with Pfizer (NYSE: PFE) during the COVID-19 pandemic, soared 20.2% through 12:50 p.m. Monday on news
The 2 Smartest Beaten-Down Biotech Stocks to Buy on the Dip
Even though broader equities have been highly volatile this year, it's still a good idea to invest in stocks for a straightforward reason. Holding shares of top companies for five years and beyond
3 No-Brainer Healthcare Stocks to Buy in June
A new month has arrived. Investors now have a fresh opportunity to buy great stocks. Three Motley Fool contributors believe they've found no-brainer healthcare stocks to buy in June. Here's why they
Terrible News for Pfizer Stock Investors
The past three years have been challenging for Pfizer (NYSE: PFE). Revenue and earnings have moved in the wrong direction, as has the company's share price. The stock is down by 56% since 2022
Beat the S&P 500 With This Cash-Gushing Dividend Stock
You don't need to uncover the next big artificial intelligence stock to outperform the broader stock market. Sometimes, consistent and profitable growth is all you need to achieve outsize investment
Does This Move Make Medtronic Stock a Buy?
Over the past few years, Medtronic (NYSE: MDT) has faced significant challenges, including a pandemic-induced slowdown, relatively slow revenue growth, and economic issues that impacted its
1 Thing Investors Must Know Before Buying the 52% Dip on UnitedHealth Group
UnitedHealth Group (NYSE: UNH) is central to the trillion-dollar U.S. healthcare industry. It's a behemoth that generates over $400 billion in annual revenue with insurance, pharmacy, care services
UnitedHealth Group Stock Is Near 5-Year Lows: Is It a Bargain Buy?
UnitedHealth Group (NYSE: UNH) is one of the biggest health insurers in the U.S. It plays a critical role in the healthcare industry, and for years, it has been a sound stock to invest in.
This
The Company Buying 23andMe Is a Pharmaceutical Giant. Here's How Investors Can Benefit From the Move.
Earlier this year, biotech company 23andMe filed for bankruptcy. The harsh reality was that its business, while enticing to people who wanted to learn about their backgrounds via DNA testing kits
Is Amgen Stock a Buy?
Amgen (NASDAQ: AMGN) is doing something unusual in 2025. The biotech giant's shares are up 7.2% for the year as I write this while most large-cap healthcare stocks struggle; yet it trades at just 13


